Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Jaguar Health Inc (NASDAQ: JAGX) closed at $0.25 down -47.76% from its previous closing price of $0.47. In other words, the price has decreased by -$47.76 from its previous closing price. On the day, 3.39 million shares were traded. JAGX stock price reached its highest trading level at $0.338 during the session, while it also had its lowest trading level at $0.225.
Ratios:
For a deeper understanding of Jaguar Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.36 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 2.13 whereas as Long-Term Debt/Eq ratio is at 1.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.
On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 4018539 and an Enterprise Value of 25861580. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.38 while its Price-to-Book (P/B) ratio in mrq is 0.19. Its current Enterprise Value per Revenue stands at 2.468 whereas that against EBITDA is -0.926.
Stock Price History:
The Beta on a monthly basis for JAGX is 0.88, which has changed by -0.94895834 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, JAGX has reached a high of $21.60, while it has fallen to a 52-week low of $0.42. The 50-Day Moving Average of the stock is -69.02%, while the 200-Day Moving Average is calculated to be -84.05%.
Shares Statistics:
For the past three months, JAGX has traded an average of 409.93K shares per day and 595700 over the past ten days. A total of 16.40M shares are outstanding, with a floating share count of 13.59M. Insiders hold about 17.12% of the company’s shares, while institutions hold 1.71% stake in the company. Shares short for JAGX as of 1740700800 were 953074 with a Short Ratio of 2.32, compared to 1738281600 on 785103. Therefore, it implies a Short% of Shares Outstanding of 953074 and a Short% of Float of 5.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 1 analysts are dedicated to thoroughly evaluating and rating the performance of Jaguar Health Inc (JAGX) in the stock market.The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.72 and low estimates of -$0.72.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$2.06, with 1 analysts recommending between -$2.06 and -$2.06.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $3.29M. There is a high estimate of $3.29M for the next quarter, whereas the lowest estimate is $3.29M.
Based on 1 analysts’ estimates, the company’s revenue will be $15.84M in the next fiscal year. The high estimate is $15.84M and the low estimate is $15.84M.
